HIV vaccine development: lessons learned to date.
Putney
S D
SD
Repligen Corporation, Cambridge, Massachusetts 02139.
D016915:AIDS Vaccines / Q000302:isolation & purification / Q000494:pharmacology*; D000818:Animals; D000939:Epitopes; D015483:HIV Antibodies / Q000096:biosynthesis; D015488:HIV Antigens; D015658:HIV Infections / Q000517:prevention & control; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007116:Immunization, Passive; D009500:Neutralization Tests; D002679:Pan troglodytes; D014611:Vaccination
D016915:AIDS Vaccines; D000939:Epitopes; D015483:HIV Antibodies; D015488:HIV Antigens